Deep-learning splice prediction links a PARP2 variant to altered protein isoforms and influenza susceptibility
By combining single-cell splicing-QTL analysis during influenza A infection with SpliceAI/Pangolin annotation and statistical fine-mapping, researchers prioritized causal splice variants. They experimentally characterized rs2297616 in PARP2: its A allele creates an alternative 5′ splice donor, adding 39 nucleotides and producing a protein isoform 13 amino acids longer. CRISPR-edited A549 cells showed the predicted splice and protein changes; the A-allele edited cells also had higher influenza A infection than G-allele cells. The variant was associated with higher viral burden in a panel of 96 lymphoblastoid cell lines.
Technology: SpliceAI and Pangolin deep-learning splice-effect predictors, integrated with single-cell scHi-HOST sQTL mapping and SuSiE statistical fine-mapping
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: They experimentally characterized rs2297616 in PARP2: its A allele creates an alternative 5′ splice donor, adding 39 nucleotides and producing a protein isoform 13 amino acids longer.
- Still unknown: The 96-donor LCL association is observational and modest (the paper reports p=0.029 for the genotype association). Infection experiments used edited A549 lung epithelial cells, not patients or an in-vivo infection model. The same locus had been linked to alternative splicing previously, but the paper provides new evidence connecting genotype to PARP2 protein isoform expression and to influenza susceptibility. Broader viral-susceptibility implications remain unproven.
- AI role: Deep-learning splice models prioritized variants predicted to alter donor/acceptor sites; statistical fine-mapping and sQTL association narrowed causal candidates. The AI-supported analysis nominated rs2297616; the authors then tested its splice and protein-isoform effects using reporter assays, CRISPR-edited A549 cells, sequencing and western blotting, and assessed influenza infection in edited cells.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13663244/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.